People · Operator
Named in public records as an officer, director or promoter · active 2020–2020 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| RenBio, Inc. | — | Biotechnology | Series A | $19.3M | $25.7M | 2020 |
Wan Feng Ting at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Wan Feng Ting on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| David Chu | 1 | 2 |
| Rachel A. Liberatore, Ph.D. | 1 | 1 |
| Zhi A. Hong, Ph.D. | 1 | 1 |
| Donald A. Tang | 1 | 1 |
| Annelyn A. O'Rourke | 1 | 1 |
| Walter A. Wang, Sr. | 1 | 1 |
| Neal Padte | 1 | 1 |
| Chi-Chuan Chen | 1 | 1 |
| Jaap A. Goudsmit, M.D., Ph.D. | 1 | 1 |
| Tamon Tseng | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.